paraquat has been researched along with talipexole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsubara, K; Ohtaki, K; Shimizu, K; Shiono, H | 1 |
| Bravo-San Pedro, JM; Fuentes, JM; Gómez-Sánchez, R; González-Polo, RA; Niso-Santano, M; Soler, G | 1 |
2 other study(ies) available for paraquat and talipexole
| Article | Year |
|---|---|
Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Animals, Newborn; Azepines; Cabergoline; Caspases; Cell Count; Cycloheximide; Dizocilpine Maleate; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ergolines; Excitatory Amino Acid Antagonists; Herbicides; Immunohistochemistry; Mesencephalon; NADPH Dehydrogenase; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Organ Culture Techniques; Paraquat; Piperazines; Protein Synthesis Inhibitors; Quinoxalines; Rats; Rats, Wistar; Selegiline; Tyrosine 3-Monooxygenase | 2003 |
The neuroprotective effect of talipexole from paraquat-induced cell death in dopaminergic neuronal cells.
Topics: Animals; Azepines; Cell Death; Cell Line, Transformed; Cell Survival; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Neurons; Neuroprotective Agents; Paraquat; Rats | 2010 |